生物基因 BIIB
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q3 | 140.08 | 106.12 | 13.42 | 3.17 | 591,400 | 467 |
| 2025Q2 | 125.59 | 106.55 | 12.44 | 4.33 | 792,700 | 635 |
| 2025Q1 | 136.84 | 121.98 | 13.54 | 1.64 | 379,600 | 241 |
| 2024Q4 | 152.92 | 151.42 | 13.65 | 1.83 | 441,400 | 267 |
| 2024Q3 | 193.84 | 103.28 | 17.48 | 2.65 | 465,800 | 389 |
| 2024Q2 | 231.82 | 99.51 | 28.93 | 4.00 | 695,300 | 584 |
| 2024Q1 | 215.63 | 120.16 | 27.00 | 2.70 | 558,500 | 393 |
| 2023Q4 | 258.77 | 123.08 | 25.65 | 1.71 | 358,900 | 250 |
| 2023Q3 | 257.01 | -112.46 | 13.97 | -0.48 | 158,800 | -68 |
| 2023Q2 | 284.85 | 82.88 | 15.47 | 4.07 | 586,900 | 592 |
| 2023Q1 | 278.03 | 115.83 | 12.83 | 2.67 | 507,700 | 388 |
| 2022Q4 | 276.92 | 118.73 | 13.92 | 3.80 | 716,900 | 550 |
| 2022Q3 | 267.00 | 59.18 | 13.53 | 7.80 | 811,400 | 1,135 |
| 2022Q2 | 203.94 | 66.24 | 14.50 | 7.21 | 840,900 | 1,058 |
| 2022Q1 | 210.60 | 175.79 | 21.35 | 2.06 | 610,700 | 304 |
| 2021Q4 | 239.92 | 144.96 | 22.65 | 2.50 | 587,100 | 368 |
| 2021Q3 | 282.99 | 272.76 | 14.00 | 2.22 | 794,000 | 329 |
| 2021Q2 | 346.27 | 83.44 | 17.31 | 2.99 | 485,700 | 449 |
| 2021Q1 | 279.75 | 208.54 | 10.65 | 2.69 | 973,900 | 410 |
| 2020Q4 | 244.86 | -74.23 | 9.42 | 2.55 | -330,600 | 358 |